dc.date.accessioned2021-06-08T15:46:15Z
dc.date.available2021-06-08T15:46:15Z
dc.date.created2021-06-08T15:46:15Z
dc.date.issued2021
dc.identifierhttps://hdl.handle.net/20.500.12866/9517
dc.identifierhttps://doi.org/10.7883/yoken.JJID.2020.729
dc.description.abstractFabry disease (FD), like COVID-19, can affect multiple organs, including the lungs. Patients with FD are expected to develop severe COVID-19, due to involvement of not only the lungs but also the kidneys and the presence of other comorbidities. We present 2 cases of mild COVID-19 in patients with FD who were infected with the COVID-19 virus. Although it is unknown whether the X chromosome mutation in patients with FD affects the development of severe COVID-19, it is suggested that it may play a protective role against COVID-19 infection. Based on these cases, we suggest that FD is not a risk factor for severe COVID-19
dc.languageeng
dc.publisherJ-STAGE
dc.relationJapanese Journal of Infectious Diseases
dc.relation1884-2836
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectCOVID-19
dc.subjectFemale
dc.subjectHumans
dc.subjectMiddle Aged
dc.subjectCOVID-19 Testing
dc.subjectCOVID-19/diagnostic imaging/*etiology/therapy
dc.subjectEnzyme Replacement Therapy
dc.subjectfabry disease
dc.subjectFabry Disease/*etiology/genetics/therapy
dc.subjectKidney/pathology
dc.subjectrare diseases
dc.titleWhen Frequent (Pandemic) Occurs in a Non-Frequent Disease: COVID-19 and Fabry Disease: Report of Two Cases
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución